Nabi(美國(guó))

Nabi Biopharmaceuticals

美國(guó)NabiBiopharmaceuticals www.nabi.com 美國(guó)Nabi生物制藥公司研發(fā)的一種用于治療尼古丁成癮和預(yù)防復(fù)吸疫苗NieVax（尼古丁接合疫苗）獲得FDA授予的快通道審批地位。該疫苗將在第二季度進(jìn)入Ⅱ期概念驗(yàn)證臨床試驗(yàn)階段，包括300位患者，試驗(yàn)結(jié)果將于2007年下半年得出。在未來(lái)幾年里，戒煙市場(chǎng)將發(fā)生明顯變化。PentaStaph（五金黃色葡萄球菌疫苗）Nab iBiopharmaceuticalsisfocusedondevelopingaseriesoffirstandsecondgenerationproductsthataddressunmetmedicalneedsandofferopportunitiesinourcorebusinessareas:nicotineaddictionandgram-positivebacterialinfections.Drivenbyourclinicaldevelopmentprograms,wearefocusedonbuildingvalueandareseekingpartnersforourvaccineprograms:NicVAX®(NicotineConjugateVaccine)andPentaStaph™(StaphylococcalPolysaccharideConjugateandToxoidVaccine).OurheadquartersislocatedinRockville,MarylandalongwithourResearchandDevelopmentfacility.